BC
VIR icon

BIT Capital’s Vir Biotechnology VIR Stock Holding History

BIT Capital’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-40,000
Closed -$1.67M – 183
2021
Q4 		$1.67M Buy
+40,000
New +$1.57M 0.13% 62

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BIT Capital's VIR Position: Q2 2026 in Review

BIT Capital increased its Vir Biotechnology (VIR) stake by 167% in Q2 2026, buying an estimated $476K and bringing the position to 80,000 shares worth $815K. The position accounts for 0.02% of the portfolio, ranked #85.

BIT Capital first reported a position in VIR in Q4 2021 and has held it in 4 quarters since. The position peaked at $1.67M in Q4 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • BIT Capital held 80,000 shares of Vir Biotechnology worth $815K as of Q2 2026.
  • BIT Capital bought 50,000 Vir Biotechnology shares in Q2 2026, an estimated $476K.
  • Vir Biotechnology made up 0.02% of BIT Capital's portfolio in Q2 2026, its #85 holding.
  • BIT Capital first reported a position in Vir Biotechnology in Q4 2021 and has held it in 4 quarters since.
  • BIT Capital's Vir Biotechnology position peaked at $1.67M in Q4 2021.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on BIT Capital's 13F filing for Q2 2026, filed 12 Aug 2026.